Indian Fluoxetine Exporters: Complete Supplier Ranking with Market Share — 522 Manufacturers (2026) — TransData Nexus

Q: Who is the largest fluoxetine buyer importing from India?

AVET PHARMACEUTICALS INC C/O (UNITED STATES) is the largest fluoxetine importer from India with a 48.0% market share and import value of $112.8M.

Q: How many fluoxetine buyers import from India?

There are 522 active fluoxetine buyers importing from India, with a combined import market of $235.3M across 3,702 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top fluoxetine buyers from India?

The top 5 fluoxetine buyers — AVET PHARMACEUTICALS INC C/O, ACCORD HEALTHCARE INC,, BROWN AND BURK LIMITED, IMRES B.V., TORRENT PHARMA INC, — together control 70.4% of total fluoxetine import value from India.

Suresh Sormare

Fluoxetine

India Pharmaceutical Trade Intelligence

$235.3M253 Suppliers101 CountriesHS 30049099

ExportsIndia → UNITED STATES65.6%India → CANADA12.9%

ImportsUNITED KINGDOM → India$6.7B GERMANY → India$738.6K

#1 Supplier: SIDMAK LABORATORIES

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $154.4M through 389 shipments. This represents a market share of 65.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• AVET PHARMACEUTICALS INC C/O - $112.8M (73.1% of country's total business)

• TORRENT PHARMA INC, - $7.9M (5.1% of country's total business)

• TIME-CAP LABS, - $2.7M (1.7% of country's total business)

• J. KNIPPER & COMPANY - $2.6M (1.7% of country's total business)

• DR. REDDYS LABORATORIES, INC - $2.6M (1.7% of country's total business)

• Rest of United States's importers - $25.9M (16.8% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $397.0K, indicating premium pricing strategy compared to the market average of $63.6K.

United States is a key market for Fluoxetine imports, representing 65.6% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Fluoxetine buyer market intelligence

1Buyer Segment Analysis

The 522 buyers of Fluoxetine imported from India can be categorized into several segments:

1. Pharmaceutical Companies: Entities like AVET Pharmaceuticals Inc. (USA, $112.82M), Accord Healthcare Inc. (Canada, $25.40M), and Dr. Reddy's Laboratories, Inc. (USA, $2.56M) are pharmaceutical manufacturers that import Fluoxetine for formulation and distribution. Their purchasing patterns typically involve large, consistent orders to meet production demands.

2. Distributors: Companies such as Brown and Burk Limited (UK, $10.59M) and Imres B.V. (Netherlands, $8.81M) act as intermediaries, supplying Fluoxetine to various healthcare providers. They often place regular orders based on market demand forecasts.

3. Contract Manufacturers: Entities like Torrent Pharma Inc. (USA, $7.94M) and Time-Cap Labs (USA, $2.66M) import Fluoxetine to manufacture products on behalf of other companies. Their procurement is project-based, aligning with contractual obligations.

4. Re-exporters: Companies such as Orion Corporation (Finland, $3.32M) may import Fluoxetine for re-export to other markets, leveraging trade agreements and logistical advantages. Their buying behavior is influenced by global market demands and regulatory environments.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Fluoxetine buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Fluoxetine (HS Code: 30049099) are as follows:

1. United States

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Fluoxetine is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic drugs.

Estimated Timeline: The NDA review process typically takes 10 months, while the ANDA process averages 8 months.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the U.S.

2. Canada

Regulatory Authority: Health Canada.

Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure the product is listed on the Drug Product Database (DPD).

Demand Drivers & Market Opportunity

TransData Nexus Fluoxetine buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Fluoxetine in importing countries is driven by several factors:

1. Disease Prevalence: Fluoxetine is primarily used to treat major depressive disorder, anxiety disorders, and certain eating disorders. According to the World Health Organization (WHO), depression affects over 264 million people globally as of 2020, indicating a substantial patient base for Fluoxetine.

2. Government Healthcare Programs: Many countries have national healthcare programs that subsidize or cover the cost of essential medicines, including Fluoxetine. For instance, the UK's National Health Service (NHS) provides Fluoxetine as part of its formulary, ensuring widespread access.

3. Universal Health Coverage Expansion: Countries expanding their universal health coverage, such as South Africa's National Health Insurance (NHI) initiative, are increasing access to essential medicines, thereby boosting demand for Fluoxetine.

4. WHO Essential Medicines List Procurement: Fluoxetine is listed on the WHO Model List of Essential Medicines, prompting many countries to include it in their national essential medicines lists and procurement programs.

5. Tender-Based Purchasing: Government and international organizations often procure medicines through tenders to ensure cost-effectiveness and supply security. The presence of 522 buyers across 101 countries, as per TransData Nexus data, indicates a competitive market where tender-based purchasing is prevalent.

These factors collectively contribute to the sustained and growing demand for Fluoxetine in the global market.

TransData Nexus Research · Government and regulatory sources

Common Questions — Fluoxetine Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest fluoxetine buyer importing from India?

Based on import volume and value, AVET PHARMACEUTICALS INC C/O (UNITED STATES) leads with $112.8M in imports and a 48.0% market share — the highest of any single fluoxetine importer. ACCORD HEALTHCARE INC, (CANADA) and BROWN AND BURK LIMITED (UNITED KINGDOM) are the next largest buyers.

QHow many companies buy fluoxetine from India?

There are 522 active fluoxetine buyers importing from India, with a combined market of $235.3M across 3,702 shipments to 101 countries. The top 5 buyers hold 70.4% of total import value, while the remaining 517 buyers handle the other 29.6%.

QWhich countries import the most fluoxetine from India?

The top importing countries for fluoxetine from India are United States (65.6%), Canada (12.9%), United Kingdom (8.1%), Netherlands (3.9%), South Africa (1.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of fluoxetine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for fluoxetine from India?

The average import transaction value for fluoxetine from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Fluoxetine buyer market intelligence

1Buyer Segment Analysis

The 522 buyers of Fluoxetine imported from India can be categorized into several segments:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Fluoxetine buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Fluoxetine (HS Code: 30049099) are as follows:

1. United States

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline: The NDA review process typically takes 10 months, while the ANDA process averages 8 months.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the U.S.

2. Canada

Regulatory Authority: Health Canada.

Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure the product is listed on the Drug Product Database (DPD).

Demand Drivers & Market Opportunity

TransData Nexus Fluoxetine buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Fluoxetine in importing countries is driven by several factors:

These factors collectively contribute to the sustained and growing demand for Fluoxetine in the global market.

TransData Nexus Research · Government and regulatory sources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fluoxetine

Fluoxetine

Who Buys Fluoxetine from India — 522 Importers Behind a $235.3M Market

Top Fluoxetine Importers — Ranked by Import Value

Top Fluoxetine Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Fluoxetine — and from which countries?

Fluoxetine — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Fluoxetine Buyers & Importers

QWho is the largest fluoxetine buyer importing from India?

QHow many companies buy fluoxetine from India?

QWhich countries import the most fluoxetine from India?

QWhat is the average import order value for fluoxetine from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Canada

3United Kingdom

4Netherlands

5South Africa

Analysis Methodology